About
Technology
Issues
FAQ
Links
Official Page
Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumab
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.